301 related articles for article (PubMed ID: 32927275)
1. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
[TBL] [Abstract][Full Text] [Related]
2. Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis.
Shi X; Xie WL; Kong WW; Chen D; Qu P
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2455-66. PubMed ID: 26381780
[TBL] [Abstract][Full Text] [Related]
3. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.
Samstad EO; Niyonzima N; Nymo S; Aune MH; Ryan L; Bakke SS; Lappegård KT; Brekke OL; Lambris JD; Damås JK; Latz E; Mollnes TE; Espevik T
J Immunol; 2014 Mar; 192(6):2837-45. PubMed ID: 24554772
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.
Gregersen I; Sandanger Ø; Askevold ET; Sagen EL; Yang K; Holm S; Pedersen TM; Skjelland M; Krohg-Sørensen K; Hansen TV; Dahl TB; Otterdal K; Espevik T; Aukrust P; Yndestad A; Halvorsen B
PLoS One; 2017; 12(11):e0188387. PubMed ID: 29176764
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
8. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals.
Boland AJ; Gangadharan N; Kavanagh P; Hemeryck L; Kieran J; Barry M; Walsh PT; Lucitt M
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):509-517. PubMed ID: 29764192
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
Paramel Varghese G; Folkersen L; Strawbridge RJ; Halvorsen B; Yndestad A; Ranheim T; Krohg-Sørensen K; Skjelland M; Espevik T; Aukrust P; Lengquist M; Hedin U; Jansson JH; Fransén K; Hansson GK; Eriksson P; Sirsjö A
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207962
[TBL] [Abstract][Full Text] [Related]
11. Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis.
Lee J; Wan J; Lee L; Peng C; Xie H; Lee C
Lipids Health Dis; 2017 Nov; 16(1):217. PubMed ID: 29151018
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.
Bakke SS; Aune MH; Niyonzima N; Pilely K; Ryan L; Skjelland M; Garred P; Aukrust P; Halvorsen B; Latz E; Damås JK; Mollnes TE; Espevik T
J Immunol; 2017 Oct; 199(8):2910-2920. PubMed ID: 28855312
[TBL] [Abstract][Full Text] [Related]
13. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts.
Stødle GS; Silva GB; Tangerås LH; Gierman LM; Nervik I; Dahlberg UE; Sun C; Aune MH; Thomsen LCV; Bjørge L; Iversen AC
Clin Exp Immunol; 2018 Jul; 193(1):84-94. PubMed ID: 29683202
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
[TBL] [Abstract][Full Text] [Related]
15. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
16. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease.
Hsieh CW; Chen YM; Lin CC; Tang KT; Chen HH; Hung WT; Lai KL; Chen DY
J Rheumatol; 2017 Aug; 44(8):1142-1150. PubMed ID: 28507179
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nuñez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E
Nature; 2010 Apr; 464(7293):1357-61. PubMed ID: 20428172
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
[TBL] [Abstract][Full Text] [Related]
20. The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis.
Khair M; Khair M; Vangaveti VN; Malabu UH
J Cardiol; 2024 Jul; 84(1):14-21. PubMed ID: 38521117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
